Deep-Brain Stimulation - Entering the Era of Human Neural-Network Modulation
NEJM 371:1369-1373, Okun, M.S., 2014
Association of Cerebral Microbleeds with Mortality in Stroke Patients Having Atrial Fibrillation
Neurol 83:1308-1315,1304, Song, T.J.,et al, 2014
Neuroimaging of Diving-Related Decompression Illness: Current Knowledge and Perspectives
AJNR 35:2039-2044, Tatuene, J.K.,et al, 2014
Menieres Disease
BMJ 349:g6544, Harcourt, J.,et al, 2014
Oral Fluoroquinolone Use and Risk of Peripheral Neuropathy
Neurol 83:1261-1263, Etminan, M.,et al, 2014
Use of Coumarin Anticoagulants and Cerebral Microbleeds in the General Population
Stroke 45:3436-3439, Akoudad, S.,et al, 2014
Aspirin for Acute Stroke of Unknown Etiology in Resourse-Limited Settings
Neurol 83:787-793, Berkowitz, A.L.,et al, 2014
Variation in Restarting Antithrombotic Drugs at Hospital Discharge after Intracerebral Hemorrhage
Stroke 45:2643-2648, Pasquini, M.,et al, 2014
Symptomatic Intracerebral Hemorrhage in Acute Ischemic Stroke After Thrombolysis With Intravenous Recombinant Tissue Plasminogen Activator
JAMA Neurol 81:1181-1185, Yaghi, S.,et al, 2014
Evaluation of a Patient with Spinal Cord Infarction after a Hypotensive Episode
Stroke 45:e203-e205, Vongveeranonchai, N.,et al, 2014
Number of Cerebral Microbleeds and Risk of Intracerebral Hemorrhage after Intravenous Thrombolysis
Stroke 45:2900-2905, Dannenberg, S.,et al, 2014
Antiplatelet Therapy May be Continued after Intracerebral Hemorrhage
Stroke 45:3149-3150,3153, Salman, R.A. & Dennis, M.S., 2014
Aspirin Should be Discontinued after Lobar Intracerebral Hemorrhage
Stroke 45:3151-3152,3153, Falcone, G.J. & Rosand, J., 2014
Stroke and the Law
Stroke 45:3141-3146, Fisher, M. & Schneider, P., 2014
Midodrine for Orthostatic Hypotension and Recurrent Reflex Syncope
Neurol 83:1170-1177, Izcovich, A.,et al, 2014
Six-Minute Magnetic Resonance Imaging Protocol for Evaluation of Acute Ischemic Stroke
Stroke 45:1985-1991, Nael, K.,et al, 2014
Balos Concentric Sclerosis
Lancet Neurol 13:740-746, Hardy, T.A. & Miller, D.H., 2014
Sudden Unilateral Painless Loss of Vision
BMJ 349:g4117, Georgalas, I.,et al, 2014
A Randomized Trial of Epidural Glucocorticoid Injections for Spinal Stenosis
NEJM 371:11-21,75, Friedly, J.L.,et al, 2014
Giant-Cell Arteritis and Polymyalgia Rheumatica
NEJM 371:50-57, Weyand, C.M. & Goronzy J.J., 2014
IgG4-Related Hypertrophic Pachymeningitis
JAMA Neurol 71:785-793, Lu, L.X.,et al, 2014
Antiepileptic Drugs for Neuropathic Pain and Fibromyalgia
JAMA 312:182-183, Moore, A.,et al, 2014
HIV Testing and Management of Newly Diagnosed HIV
BMJ 349:g4275, Rayment, M.,et al, 2014
Palliative Care and Neurology
Neurol 83:561-567, Boersma, I.,et al, 2014
The Management of Spasticity in Adults
BMJ 349:g4737, Nair, K.P.S. & Marsden, J., 2014
Amyloid-Beta Related Angiitis of the Central Nervous System: Case Report and Topic Review
Front Neurol 5:1-4, Nouh, A.,et al, 2014
Alleviating Manoeuvres (Sensory Tricks) in Cervical Dystonia
JNNP 85:882-884, Patel, N.,et al, 2014
Brain Abscess
NEJM 371:447-456, Brouwer, M.C.,et al, 2014
Avoid Surgery as First Line Treatment for Non-Specific Low Back Pain
BMJ 348:g4214, Peul, W.C.,et al, 2014
Incidence of Symptomatic Hemorrhage in Patients with Lobar Microbleeds
Stroke 45:2280-2285, Van Etten, E.S.,et al, 2014
Novel Factor Xa Inhibitor for the Treatment of Cerebral Venous and Sinus Thrombosis
Stroke 45:2469-2471, Geisbusch, C.,et al, 2014
Intracranial Hemorrhage Mortality in Atrial Fibrillation Patients Treated with Dabigatran or Warfarin
Stroke 45:2286-2291, Alonso, A.,et al, 2014
Mold Infections of the Central Nervous System
NEJM 371:150-160, McCarthy, M.,et al, 2014
Cerebrovascular Events in 21 105 Patients with Atrial Fibrillation Randomized to Edoxaban Versus Warfarin
Stroke 45:2372-2378, Giugliano, R.P.,et al, 2014
Legal and Ethical Implications in the Evaluation and Management of Sports-Related Concussion
Neurol 83:352-359, Kirschen, M.P.,et al, 2014
Histoplasmosis in Patient with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS)
Medicine 93:11-18, Myint, T.,et al, 2014
Nocardiosis of the Central Nervous System
Medicine 93:19-32, Anagnostou, T.,et al, 2014
Symptomatic Peripheral Mycotic Aneurysms Due to Infective Endocarditis
Medicine 93:42-52, Gonzalez, I.,et al, 2014
Preadmission Oral Anticoagulant Treatment and Clinical Outcome Among Patients Hospitalized with Acute Stroke and Atrial Fibrillation
Stroke 45:168-175, Johnsen, S.P.,et al, 2014
Brush Sign on 3-T T2* - Weighted MRI as a Potential Predictor of Hemorrhagic Transformation After Tissue Plasminogen Activator Therapy
Stroke 45:274-276, Terasawa, Y.,et al, 2014
Anticoagulants for Cerebral Venous Thrombosis
Stroke 45:298-304,8, Cundiff, D.K., 2014
Clinical Reasoning: A 42-year-old Man with Severe Headache, Fever, and Acute Coma
Neurol 82:e9-e13, Han, F.,et, 2014
Mystery Case: A 63-year-old Man with Progressive Proximal Pain and Weakness
Neurol 82:e26-e29, Scripko, P.D.,et al, 2014
Cerebral Venous Thrombosis
Stroke 45:e16-e18, Gulati, D.,et al, 2014
Diagnosis and Management of Marchiafava-Bignami Disease: A Review of CT/MRI Confirmed Cases
JNNP 85:168-173, Hillborn, M.,et al, 2014
Addition of Hyperacute MRI Aids in Patient Selection, Decreasing the Use of Endovascular Stroke Therapy
Stroke 45:467-472, Wisco, D.,et al, 2014
Summary of Evidence-Based Guideline Update: Prevention of Stroke in Nonvalvular Atrial Fibrillation
Neurol 82:716-724, Culebras, A.,et al, 2014
4.5-Hour Time Window for Intravenous Thrombolysis with Recombinant Tissue-Type Plasminogen Activator is Established Firmly
Stroke 45:912-913,916, Schellinger, P.D. & Kohrmann, M., 2014
The 4.5-HourTime Window for Intravenous Thrombolysis with Intravenous Tissue-Type Plasminogen Activator is Not Firmly Established
Stroke 45:915-915,916, Wechsler, L.R., 2014
Fibromyalgia
BMJ 345:g1224, Rahman, A.,et al, 2014